Literature DB >> 19964620

Emerging translational bioinformatics: knowledge-guided biomarker identification for cancer diagnostics.

John H Phan1, Qiqin Yin-Goen, Andrew N Young, May D Wang.   

Abstract

Advances in high-throughput genomic and proteomic technology have led to a growing interest in cancer biomarkers. These biomarkers can potentially improve the accuracy of cancer subtype prediction and subsequently, the success of therapy. In this paper, we describe emerging technology for enabling translational bioinformatics by improving biomarker identification. Specifically, we present an application that uses prior knowledge to identify the most biologically relevant gene ranking algorithm. Identification of statistically and biologically relevant biomarkers from high-throughput data can be unreliable due to the nature of the data--e.g., high technical variability, small sample size, and high dimension size. Furthermore, due to the lack of available training samples, data-driven machine learning methods are often insufficient without the support of knowledge-based algorithms. As a case study, we apply these knowledge-driven methods to renal cancer data and identify genes that are potential biomarkers for cancer subtype classification.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19964620      PMCID: PMC5003034          DOI: 10.1109/IEMBS.2009.5333937

Source DB:  PubMed          Journal:  Conf Proc IEEE Eng Med Biol Soc        ISSN: 1557-170X


  13 in total

1.  Significance analysis of microarrays applied to the ionizing radiation response.

Authors:  V G Tusher; R Tibshirani; G Chu
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-17       Impact factor: 11.205

2.  Biomarker identification by feature wrappers.

Authors:  M Xiong; X Fang; J Zhao
Journal:  Genome Res       Date:  2001-11       Impact factor: 9.043

3.  Class prediction and discovery using gene microarray and proteomics mass spectroscopy data: curses, caveats, cautions.

Authors:  R L Somorjai; B Dolenko; R Baumgartner
Journal:  Bioinformatics       Date:  2003-08-12       Impact factor: 6.937

4.  A theoretical analysis of the selection of differentially expressed genes.

Authors:  Sach Mukherjee; Stephen J Roberts
Journal:  J Bioinform Comput Biol       Date:  2005-06       Impact factor: 1.122

5.  Selecting clinically-driven biomarkers for cancer nanotechnology.

Authors:  John H Phan; Andrew N Young; May D Wang
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2006

Review 6.  Colorectal cancer and genetic alterations in the Wnt pathway.

Authors:  S Segditsas; I Tomlinson
Journal:  Oncogene       Date:  2006-12-04       Impact factor: 9.867

7.  Vascular endothelial growth factor (VEGF-C1)-dependent inflammatory response of podocytes in nephrotic syndrome glomerulopathies in children: an immunohistochemical approach.

Authors:  D Ostalska-Nowicka; J Zachwieja; M Nowicki; E Kaczmarek; A Siwinska; M Witt
Journal:  Histopathology       Date:  2005-02       Impact factor: 5.087

8.  GBAS, a novel gene encoding a protein with tyrosine phosphorylation sites and a transmembrane domain, is co-amplified with EGFR.

Authors:  X Y Wang; D I Smith; W Liu; C D James
Journal:  Genomics       Date:  1998-05-01       Impact factor: 5.736

9.  Improving the efficiency of biomarker identification using biological knowledge.

Authors:  John H Phan; Qiqin Yin-Goen; Andrew N Young; May D Wang
Journal:  Pac Symp Biocomput       Date:  2009

10.  Promotion of cancer cell migration: an insulin-like growth factor (IGF)-independent action of IGF-binding protein-6.

Authors:  Ping Fu; Julian A Thompson; Leon A Bach
Journal:  J Biol Chem       Date:  2007-05-22       Impact factor: 5.157

View more
  1 in total

1.  Development and validation of a novel molecular biomarker diagnostic test for the early detection of sepsis.

Authors:  Allison Sutherland; Mervyn Thomas; Roslyn A Brandon; Richard B Brandon; Jeffrey Lipman; Benjamin Tang; Anthony McLean; Ranald Pascoe; Gareth Price; Thu Nguyen; Glenn Stone; Deon Venter
Journal:  Crit Care       Date:  2011-06-20       Impact factor: 9.097

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.